Charles E. Melançon

1.8k total citations
30 papers, 1.4k citations indexed

About

Charles E. Melançon is a scholar working on Molecular Biology, Pharmacology and Organic Chemistry. According to data from OpenAlex, Charles E. Melançon has authored 30 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 14 papers in Pharmacology and 11 papers in Organic Chemistry. Recurrent topics in Charles E. Melançon's work include Microbial Natural Products and Biosynthesis (14 papers), Carbohydrate Chemistry and Synthesis (11 papers) and Genomics and Phylogenetic Studies (8 papers). Charles E. Melançon is often cited by papers focused on Microbial Natural Products and Biosynthesis (14 papers), Carbohydrate Chemistry and Synthesis (11 papers) and Genomics and Phylogenetic Studies (8 papers). Charles E. Melançon collaborates with scholars based in United States, China and Finland. Charles E. Melançon's co-authors include Hung‐wen Liu, Christopher J. Thibodeaux, Peter G. Schultz, Dan Groff, Hyun Soo Lee, Jiantao Guo, Hua Zhang, Lin Hong, Hyung‐Jin Kwon and Zongbao K. Zhao and has published in prestigious journals such as Nature, Journal of the American Chemical Society and Angewandte Chemie International Edition.

In The Last Decade

Charles E. Melançon

29 papers receiving 1.4k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Charles E. Melançon 1.1k 603 517 250 124 30 1.4k
Shanteri Singh 1.2k 1.1× 490 0.8× 492 1.0× 161 0.6× 127 1.0× 58 1.6k
Yi‐Ling Du 868 0.8× 389 0.6× 551 1.1× 144 0.6× 115 0.9× 46 1.3k
Yasushi Ogasawara 937 0.8× 427 0.7× 566 1.1× 154 0.6× 92 0.7× 74 1.5k
Jarmo Niemi 979 0.9× 348 0.6× 860 1.7× 213 0.9× 173 1.4× 51 1.4k
Hei Chan Lee 777 0.7× 208 0.3× 648 1.3× 161 0.6× 60 0.5× 55 1.0k
Gong‐Li Tang 1.5k 1.3× 747 1.2× 1.4k 2.8× 408 1.6× 105 0.8× 118 2.3k
Mikko Metsä‐Ketelä 1.1k 1.0× 414 0.7× 1.2k 2.3× 430 1.7× 105 0.8× 72 1.8k
Joseph A. Chemler 1.1k 1.0× 174 0.3× 662 1.3× 266 1.1× 63 0.5× 21 1.4k
Mohammad Nur‐e‐Alam 767 0.7× 324 0.5× 540 1.0× 162 0.6× 94 0.8× 87 1.3k
Hong Fu 910 0.8× 344 0.6× 907 1.8× 221 0.9× 28 0.2× 37 1.4k

Countries citing papers authored by Charles E. Melançon

Since Specialization
Citations

This map shows the geographic impact of Charles E. Melançon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles E. Melançon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles E. Melançon more than expected).

Fields of papers citing papers by Charles E. Melançon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles E. Melançon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles E. Melançon. The network helps show where Charles E. Melançon may publish in the future.

Co-authorship network of co-authors of Charles E. Melançon

This figure shows the co-authorship network connecting the top 25 collaborators of Charles E. Melançon. A scholar is included among the top collaborators of Charles E. Melançon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles E. Melançon. Charles E. Melançon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Akhgari, Amir, Bikash Baral, David P. Fewer, et al.. (2022). Single cell mutant selection for metabolic engineering of actinomycetes. Metabolic Engineering. 73. 124–133. 11 indexed citations
2.
Melançon, Charles E., et al.. (2021). Biosynthesis of Diverse Type II Polyketide Core Structures in Streptomyces coelicolor M1152. ACS Synthetic Biology. 10(2). 243–251. 9 indexed citations
3.
Chen, Shifu, et al.. (2020). A computational toolset for rapid identification of SARS-CoV-2, other viruses and microorganisms from sequencing data. Briefings in Bioinformatics. 22(2). 924–935. 23 indexed citations
4.
Metsä‐Ketelä, Mikko, et al.. (2020). Structural characterization of three noncanonical NTF2-like superfamily proteins: implications for polyketide biosynthesis. Acta Crystallographica Section F Structural Biology Communications. 76(8). 372–383. 12 indexed citations
5.
Wu, Hao, et al.. (2019). Mutational landscape of early-stage non-small cell lung cancer patients using a 451 gene panel.. Journal of Clinical Oncology. 37(15_suppl). e20048–e20048. 1 indexed citations
6.
He, Jingxuan & Charles E. Melançon. (2018). Genetic Incorporation of Unnatural Amino Acids into Proteins of Interest in Streptomyces venezuelae ATCC 15439. Methods in molecular biology. 1728. 155–168. 1 indexed citations
7.
8.
Ogasawara, Yasushi, Norah Torrez‐Martinez, Anthony D. Aragon, et al.. (2015). High-Quality Draft Genome Sequence of Actinobacterium Kibdelosporangium sp. MJ126-NF4, Producer of Type II Polyketide Azicemicins, Using Illumina and PacBio Technologies. Genome Announcements. 3(2). 5 indexed citations
9.
10.
11.
Bologa, Cristian, Oleg Ursu, Tudor I. Oprea, Charles E. Melançon, & George P. Tegos. (2013). Emerging trends in the discovery of natural product antibacterials. Current Opinion in Pharmacology. 13(5). 678–687. 40 indexed citations
12.
Guo, Jiantao, Charles E. Melançon, Hyun Soo Lee, Dan Groff, & Peter G. Schultz. (2009). Evolution of Amber Suppressor tRNAs for Efficient Bacterial Production of Proteins Containing Nonnatural Amino Acids. Angewandte Chemie International Edition. 48(48). 9148–9151. 141 indexed citations
13.
Melançon, Charles E. & Peter G. Schultz. (2009). One plasmid selection system for the rapid evolution of aminoacyl-tRNA synthetases. Bioorganic & Medicinal Chemistry Letters. 19(14). 3845–3847. 39 indexed citations
14.
Hong, Lin, Zongbao K. Zhao, Charles E. Melançon, Hua Zhang, & Hung‐wen Liu. (2008). In Vitro Characterization of the Enzymes Involved in TDP- d -Forosamine Biosynthesis in the Spinosyn Pathway of Saccharopolyspora spinosa. Journal of the American Chemical Society. 130(14). 4954–4967. 65 indexed citations
15.
Thibodeaux, Christopher J., Charles E. Melançon, & Hung‐wen Liu. (2008). Natural‐Product Sugar Biosynthesis and Enzymatic Glycodiversification. Angewandte Chemie International Edition. 47(51). 9814–9859. 354 indexed citations
16.
Melançon, Charles E. & Hung‐wen Liu. (2007). Engineered Biosynthesis of Macrolide Derivatives Bearing the Non-Natural Deoxysugars 4- epi - d -Mycaminose and 3- N -Monomethylamino-3-Deoxy- d -Fucose. Journal of the American Chemical Society. 129(16). 4896–4897. 23 indexed citations
17.
Thibodeaux, Christopher J., Charles E. Melançon, & Hung‐wen Liu. (2007). Unusual sugar biosynthesis and natural product glycodiversification. Nature. 446(7139). 1008–1016. 272 indexed citations
18.
19.
Melançon, Charles E., Haruko Takahashi, & Hung‐wen Liu. (2004). Characterization of tylM3/tylM2 and mydC/mycB Pairs Required for Efficient Glycosyltransfer in Macrolide Antibiotic Biosynthesis. Journal of the American Chemical Society. 126(51). 16726–16727. 40 indexed citations
20.
Borisova, Svetlana A., Lishan Zhao, Charles E. Melançon, Chai‐Lin Kao, & Hung‐wen Liu. (2004). Characterization of the Glycosyltransferase Activity of DesVII:  Analysis of and Implications for the Biosynthesis of Macrolide Antibiotics. Journal of the American Chemical Society. 126(21). 6534–6535. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shanteri Singh Breakdown of academic impact, for papers by Yi‐Ling Du Breakdown of academic impact, for papers by Yasushi Ogasawara Breakdown of academic impact, for papers by Jarmo Niemi Breakdown of academic impact, for papers by Hei Chan Lee Breakdown of academic impact, for papers by Gong‐Li Tang Breakdown of academic impact, for papers by Mikko Metsä‐Ketelä Breakdown of academic impact, for papers by Joseph A. Chemler Breakdown of academic impact, for papers by Mohammad Nur‐e‐Alam Breakdown of academic impact, for papers by Hong Fu
Rankless by CCL
2026